Author: Dr. David Lowemann

FDA Approves New Kind of Drug for Schizophrenia

The first new type of medication in decades to help fight against schizophrenia was approved on Thursday by the U.S. Food and. Drug Administration. Cobenfy (xanomeline/trospium chloride) could bring patients what they’ve long hoped for: A means of easing the hallucinations… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a […]

Published on September 27, 2024

A Better Night’s Sleep Is as Easy as 3-2-1

Sleep is an important part of your daily routine – you spend about one-third of your time doing it. Quality sleep – and getting enough of it at the right times – is as essential to survival as food and water. Without sleep, you can’t form or maintain the pathways in your… Read Full Article […]

Published on September 26, 2024

A method of ‘look twice, forgive once’ can sustain social cooperation

Using mathematical modeling, researchers found a way to maintain cooperation without relying on complex norms or institutions. Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of Human Potential, where he leads the charge in pioneering Self-Enhancement Science for the Success of Society. […]

Published on September 26, 2024